Gene therapy
•Download as PPTX, PDF•
9 likes•526 views
This document provides an overview of gene therapy. It discusses the definition of gene therapy as inserting genes into cells to treat disease. The history of gene therapy is described, including early research in the 1970s and the first human clinical trial in 1990 to treat ADA deficiency. The document outlines the main types of gene therapy as somatic, germline, and preventative. It also discusses gene delivery methods using viral and non-viral vectors and the advantages and disadvantages of gene therapy.
Report
Share
Report
Share
Recommended
Gene therapy
include histry, introduction ,classisification, uses, advancement and role of health personnels in it
Gene therapy
Gene therapy involves delivering genes to correct genetic defects. It can augment or inhibit gene expression. Key steps include identifying the defective gene, cloning the normal gene, selecting a target cell/tissue, and inserting the gene. Genes can be delivered ex vivo by modifying cells outside the body or in vivo by direct gene transfer. Viral vectors like retroviruses are commonly used, but pose risks like activating proto-oncogenes. Gene therapy aims to treat genetic disorders and acquired diseases.
Gene therapy pp
Gene therapy is a technique used to substitute defective genes that cause diseases with functional genes. It involves identifying the defective gene, extracting DNA, inserting a functional gene, and reinserting the modified DNA. There are two main types of gene therapy - somatic cell gene therapy, which treats only the individual and is not hereditary, and germline cell gene therapy, which could affect future generations but may be most effective. Gene therapy delivers the new genes via viral or bacterial vectors and holds promise to cure genetic diseases but also poses risks such as immune reactions or unintended effects.
Genetherapy
Gene therapy involves introducing normal genes into patients to replace abnormal genes that cause disease. Viruses are often used as vectors to deliver therapeutic genes to target cells. While promising for treating genetic disorders, gene therapy faces challenges like short-lived effects, immune responses, and difficulties targeting multi-gene disorders. It also raises ethical issues around heritable genetic modifications and access to expensive new treatments. Continued research aims to address these scientific and ethical considerations to realize gene therapy's potential.
Gen therapy
Gene therapy seeks to modify or manipulate genes to treat diseases. There are three main strategies for gene therapy: gene augmentation therapy which introduces a normal gene to compensate for an abnormal gene, targeted killing of specific cells, and targeted inhibition of gene expression. Gene therapy can be somatic, affecting most body cells, or germline, affecting eggs or sperm. Viral vectors are commonly used to deliver genes into cells, but non-viral methods also exist. Gene editing tools like ZFNs, TALENs, and CRISPR-Cas systems can also be used to precisely alter genes.
Gene therapy
This document summarizes the history and development of gene therapy from the 1950s to the present. It discusses key events like the isolation of genes in the 1970s and 1980s and the first human gene therapy treatment in 1990. It outlines various gene therapy strategies like ex vivo and in vivo approaches and delivery methods like viruses, liposomes, microinjection, and electroporation. Challenges of gene therapy are also summarized like ethical issues, high costs, and ensuring safety. The document aims to provide an overview of the progress of gene therapy and remaining barriers to its clinical application and acceptance.
About The Gene Therapy
Gene therapy is an experimental technique that uses genes to treat or prevent disease. The slides explain what is gene tharapy? Types of gene therapy. http://www.wesrch.com/
GENE THERAPY
GENE THERAPY, HISTORY, TYPES, SOMATIC CELL GENE THERAPY, GERM LINE GENE THERAPY, APPLICATIONS, PRINCIPLES of RNA & DNA ESTIMATION, METHODS OF ESTIMATION.
Recommended
Gene therapy
include histry, introduction ,classisification, uses, advancement and role of health personnels in it
Gene therapy
Gene therapy involves delivering genes to correct genetic defects. It can augment or inhibit gene expression. Key steps include identifying the defective gene, cloning the normal gene, selecting a target cell/tissue, and inserting the gene. Genes can be delivered ex vivo by modifying cells outside the body or in vivo by direct gene transfer. Viral vectors like retroviruses are commonly used, but pose risks like activating proto-oncogenes. Gene therapy aims to treat genetic disorders and acquired diseases.
Gene therapy pp
Gene therapy is a technique used to substitute defective genes that cause diseases with functional genes. It involves identifying the defective gene, extracting DNA, inserting a functional gene, and reinserting the modified DNA. There are two main types of gene therapy - somatic cell gene therapy, which treats only the individual and is not hereditary, and germline cell gene therapy, which could affect future generations but may be most effective. Gene therapy delivers the new genes via viral or bacterial vectors and holds promise to cure genetic diseases but also poses risks such as immune reactions or unintended effects.
Genetherapy
Gene therapy involves introducing normal genes into patients to replace abnormal genes that cause disease. Viruses are often used as vectors to deliver therapeutic genes to target cells. While promising for treating genetic disorders, gene therapy faces challenges like short-lived effects, immune responses, and difficulties targeting multi-gene disorders. It also raises ethical issues around heritable genetic modifications and access to expensive new treatments. Continued research aims to address these scientific and ethical considerations to realize gene therapy's potential.
Gen therapy
Gene therapy seeks to modify or manipulate genes to treat diseases. There are three main strategies for gene therapy: gene augmentation therapy which introduces a normal gene to compensate for an abnormal gene, targeted killing of specific cells, and targeted inhibition of gene expression. Gene therapy can be somatic, affecting most body cells, or germline, affecting eggs or sperm. Viral vectors are commonly used to deliver genes into cells, but non-viral methods also exist. Gene editing tools like ZFNs, TALENs, and CRISPR-Cas systems can also be used to precisely alter genes.
Gene therapy
This document summarizes the history and development of gene therapy from the 1950s to the present. It discusses key events like the isolation of genes in the 1970s and 1980s and the first human gene therapy treatment in 1990. It outlines various gene therapy strategies like ex vivo and in vivo approaches and delivery methods like viruses, liposomes, microinjection, and electroporation. Challenges of gene therapy are also summarized like ethical issues, high costs, and ensuring safety. The document aims to provide an overview of the progress of gene therapy and remaining barriers to its clinical application and acceptance.
About The Gene Therapy
Gene therapy is an experimental technique that uses genes to treat or prevent disease. The slides explain what is gene tharapy? Types of gene therapy. http://www.wesrch.com/
GENE THERAPY
GENE THERAPY, HISTORY, TYPES, SOMATIC CELL GENE THERAPY, GERM LINE GENE THERAPY, APPLICATIONS, PRINCIPLES of RNA & DNA ESTIMATION, METHODS OF ESTIMATION.
gene therapy.
Gene therapy involves inserting normal genes into individuals to replace defective genes that cause disease. It has been used to treat various genetic diseases and cancers since the 1990s. While it offers promise for permanent treatment, gene therapy still faces challenges like short-term effects, immune responses, high costs, and difficulties with gene delivery methods that have limited its effectiveness so far. Continued research aims to overcome these obstacles.
Gene rx [autosaved]
Gene therapy involves introducing genetic material into cells to treat or prevent disease. It has the potential to cure genetic disorders by correcting the underlying genetic defect. There are two main types - somatic gene therapy, which affects only targeted cells and is safer, and germline gene therapy which can permanently alter the genes and be passed to offspring. Recent advances include FDA-approved CAR-T immunotherapies for cancer and the first gene therapy approved for an inherited retinal disease. Challenges remain regarding delivery methods, safety, and ethical issues.
Gene therapy
Gene therapy is a strategy to treat disease by correcting defective genes or modifying gene expression. The first approved gene therapy experiment occurred in 1990 and treated a patient with ADA-SCID by inserting genes into their cells. There are two main approaches to gene therapy - in vivo and ex vivo. In vivo therapy involves direct injection of vectors into the body, while ex vivo therapy genetically modifies cells outside the body before reintroducing them. Viral vectors like adenoviruses are commonly used to deliver therapeutic genes, but carry risks like immune responses.
Gene therapy presentation
Gene therapy is a technique for correcting defective genes that cause disease. It works by inserting a normal gene to replace a missing or defective one. The first human gene therapy treatment was in 1990 for ADA deficiency. There are two main types - germline alters genes in sperm/eggs and is inheritable, while somatic only affects the patient. Delivery methods include viruses, electroporation, gene guns, and chemicals. Applications show promise for diseases like Parkinson's, Alzheimer's, cystic fibrosis and cancer. Current trends include improving viral vectors and combining gene and cell therapies.
Gene therapy
Gene therapy is an approach to treating diseases by modifying or correcting abnormal genes. It can involve replacing a mutated gene, inactivating an abnormal gene, or introducing a new gene. While the concept was introduced in the 1960s, the first approved human gene therapy trial took place in 1990. Since then, gene therapy has successfully treated various diseases like blindness, immune deficiencies, and Parkinson's disease symptoms. Viral and non-viral vectors are used to deliver therapeutic genes, with both methods having advantages and disadvantages. Ongoing research continues to expand the diseases that can be treated with this promising approach.
1. gene therapy
Gene therapy involves inserting normal genes into a person's cells to treat a disease. There are several strategies for gene therapy, including ex vivo and in vivo methods. Viral vectors are commonly used to deliver therapeutic genes to target cells. However, gene therapy has faced challenges such as short-lived effects, immune responses, and safety issues with viral vectors. Continued research is working to overcome these issues and further develop promising applications of gene therapy.
Gene therapy
BASICS OF GENE THERAPY
INTRODUCTION,HISTORY,TYPES, USES, ADVANTAGES, DISADVANTAGES, DRAWBACKS, GENETIC ENGINEERING,REGULATION
Gene theary seminar
Gene therapy involves introducing genetic material into cells to treat disease. It is used for inherited disorders, cancers, and infectious diseases. Viruses are commonly used as vectors to deliver therapeutic genes, though safety issues exist. Some early successes included treating severe combined immunodeficiency using retroviruses to deliver the ADA gene ex vivo. However, the first death in gene therapy occurred treating ornithine transcarbamylase deficiency using an adenovirus vector, highlighting the risks. Improved delivery methods like liposomes may help overcome current limitations and advance this promising approach.
Gene therapy
Gene therapy , Nucleic acids , GENES , ADA-SCID(Severe combined immunodeficiency) , APPROACHES IN GENE THERAPY : Types of gene therapy , somatic gene therapy , germ line gene therapy , Gene modification , gene replacement , gene correction , gene augmentation , Gene transfer methods , viral gene transfer (biological) , non viral gene transfer : physical method ,chemical method , retrovirus vector system , adenovirus vector system , Adeno associated virus vector , Herpex simplex virus vector , Electroporation , Microinjection , Gene Gun , Calcium phosphate mediated DNA transfer , Liposome mediated gene transfer , Potential target diseases for Gene Therapy , GENE THERAPY USED TO TREAT TYPE I DIABETES , GENE THERAPY FOR CANCER TREATMENT , PARKINSON’S DISEASE , GENE THERAPY TREATMENT FOR ADA-SCID , GENE THERAPY FOR CYSTIC FIBROSI S, HEMOPHILIA , BLINDNESS
Gene therapy , Nucleic acids , GENES , ADA-SCID(Severe combined immunodeficiency) , APPROACHES IN GENE THERAPY : Types of gene therapy , somatic gene therapy , germ line gene therapy , Gene modification , gene replacement , gene correction , gene augmentation , Gene transfer methods , viral gene transfer (biological) , non viral gene transfer : physical method ,chemical method , retrovirus vector system , adenovirus vector system , Adeno associated virus vector , Herpex simplex virus vector , Electroporation , Microinjection , Gene Gun , Calcium phosphate mediated DNA transfer , Liposome mediated gene transfer , Potential target diseases for Gene Therapy , GENE THERAPY USED TO TREAT TYPE I DIABETES , GENE THERAPY FOR CANCER TREATMENT , PARKINSON’S DISEASE , GENE THERAPY TREATMENT FOR ADA-SCID , GENE THERAPY FOR CYSTIC FIBROSI S, HEMOPHILIA , BLINDNESS
Gene therapy
This document provides information about gene therapy. It discusses that gene therapy involves genetically modifying patient cells to treat or alleviate disease. There are two main types - ex vivo therapy where cells are modified outside the body and transplanted back in, and in vivo therapy where genetic material is directly transferred into patient cells. Viruses like retroviruses, adenoviruses, and lentiviruses are often used as vectors to deliver genetic material due to their ability to efficiently transfer genes. The document outlines different applications of gene therapy and discusses strategies used depending on disease characteristics.
Gene therapy- The hope beyond Myth
Gene therapy is an experimental technique that uses genes to treat or prevent disease. It works by inserting a normal gene to replace a defective gene that is causing disease. Researchers are studying gene therapy for diseases like cancer, HIV, hemophilia, blindness, and Parkinson's disease. There are two main types - germline gene therapy, which results in permanent changes that can be inherited, and somatic gene therapy, which only affects the patient. Gene delivery methods include viral vectors like retroviruses and adenoviruses, as well as non-viral methods using physical approaches or chemical carriers like liposomes and polymers. Some successful applications of gene therapy include treating blindness and reducing Parkinson's disease symptoms.
Human gene therapy
Gene Therapy, Somatic cell gene therapy, germ line gene therapy, classical gene therapy, non-classical gene therapy, targets of gene therapy, barriers of gene therapy, ex vivo gene therapy, in vivo gene therapy, vectors for gene delivery, antisense therapy
Gene therapy
These slide include gene therapy defines with their types like Germ line gene therapy,Somatic gene therapy.
with Need of Gene therapy
strategies of gene therapy
Methods of Gene transfer & with
GENE THERAPY FOR INHERITED DISORDERS
Gene therapy
This document discusses gene therapy, including:
- Gene therapy involves inserting a normal gene to replace an abnormal gene responsible for disease.
- There are two main types: germ line therapy affects future generations, while somatic therapy only affects the individual.
- The basic process involves researching the defective gene, copying the normal gene, and inserting it into cells.
- Gene therapy could potentially replace defective genes, deliver genes to treat cancer or provide immunity, and stimulate tissue growth or healing. However, it also faces challenges like high costs and ensuring genes only target intended cells. Examples where it has been used include hemophilia, blindness, cancer, and Parkinson's disease.
Gene therapy
It is a form of therapy that involves inserting one or more corrective genes that have been designed in the laboratory, into the genetic material of a patient's cells to cure a genetic disease.
Types: somatic and germ cell gene therapy.
Submitted to: Dr. Ankit Sharma
Strategies of gene therapy
Gene therapy involves introducing DNA into a patient's cells to treat a disease. There are four main strategies of gene therapy: gene augmentation therapy which adds a functional gene; targeted killing of specific cells like cancer cells; targeted mutation correction; and targeted inhibition of gene expression. Gene therapy shows promise for diseases like cystic fibrosis, hemophilia, cancer and more. Challenges remain around safely delivering genes to the right cells and avoiding immune responses.
GENE THERAPHY
This document provides an overview of gene therapy. It defines key terms like genetics, genes, chromosomes, and therapy. It explains that gene therapy involves inserting a normal gene to replace an abnormal gene causing disease. Viruses and non-viral methods can be used as vectors to deliver therapeutic genes. While some gene therapies have shown promise for diseases like Parkinson's and immune deficiencies, the field has also faced challenges. Safety issues in early trials halted some research, but recent studies demonstrate progress in refining methods and potentially treating diseases like sickle cell anemia.
Gene Therapy
In this slide, You will get to learn abut Gene Therapy and different types of gene therapy. Various method of Gene Therapy and Advantage & Disadvantage and Recent advances in Gene Therapy.
Gene therapy
Basic principles of genetics and the basic understanding of gene therapy and its applications in therapeutics.
Gene therapy for Biotechnologist
This document discusses gene therapy, including its history, mechanisms, applications, challenges, and recent developments. It provides an overview of the first human gene therapy trials in 1990 for severe combined immunodeficiency, as well as both successful and unsuccessful early gene therapy cases. Recent progress includes using gene therapy to potentially treat Parkinson's disease, cancer, blood disorders, and inherited blindness. Overall, the document outlines the key concepts and timeline of gene therapy from its beginnings to current research.
Gene therapy
This document discusses gene therapy, including its strategies, methods of delivery, history, and applications. It provides an overview of key concepts such as:
1. Gene therapy aims to treat genetic diseases by inserting normal genes into cells to compensate for abnormal genes. Strategies include gene replacement, gene augmentation, and gene inhibition.
2. Viruses are commonly used as vectors to deliver therapeutic genes. Retroviruses and adenoviruses integrate into the genome but can cause mutations, while adenoviruses are safer but less efficient.
3. The basic process involves isolating the normal gene, inserting it into a viral vector, infecting target cells, and having the cells produce functional proteins to return to
Gene therapy
Gene therapy involves inserting normal genes into cells to treat genetic diseases. There are two main methods - using viruses as vectors to deliver genes (viral vectors) or delivering naked DNA. Researchers are studying gene therapy for diseases like cancer, HIV, hemophilia and more. Some successes include treating blindness caused by a genetic defect using a virus to deliver a healthy gene to the eyes. Gene therapy has also reduced Parkinson's disease symptoms by delivering a gene to the brain to increase inhibitory neurotransmitters. While offering hope, gene therapy also faces challenges in terms of safety, cost and ethical issues.
More Related Content
What's hot
gene therapy.
Gene therapy involves inserting normal genes into individuals to replace defective genes that cause disease. It has been used to treat various genetic diseases and cancers since the 1990s. While it offers promise for permanent treatment, gene therapy still faces challenges like short-term effects, immune responses, high costs, and difficulties with gene delivery methods that have limited its effectiveness so far. Continued research aims to overcome these obstacles.
Gene rx [autosaved]
Gene therapy involves introducing genetic material into cells to treat or prevent disease. It has the potential to cure genetic disorders by correcting the underlying genetic defect. There are two main types - somatic gene therapy, which affects only targeted cells and is safer, and germline gene therapy which can permanently alter the genes and be passed to offspring. Recent advances include FDA-approved CAR-T immunotherapies for cancer and the first gene therapy approved for an inherited retinal disease. Challenges remain regarding delivery methods, safety, and ethical issues.
Gene therapy
Gene therapy is a strategy to treat disease by correcting defective genes or modifying gene expression. The first approved gene therapy experiment occurred in 1990 and treated a patient with ADA-SCID by inserting genes into their cells. There are two main approaches to gene therapy - in vivo and ex vivo. In vivo therapy involves direct injection of vectors into the body, while ex vivo therapy genetically modifies cells outside the body before reintroducing them. Viral vectors like adenoviruses are commonly used to deliver therapeutic genes, but carry risks like immune responses.
Gene therapy presentation
Gene therapy is a technique for correcting defective genes that cause disease. It works by inserting a normal gene to replace a missing or defective one. The first human gene therapy treatment was in 1990 for ADA deficiency. There are two main types - germline alters genes in sperm/eggs and is inheritable, while somatic only affects the patient. Delivery methods include viruses, electroporation, gene guns, and chemicals. Applications show promise for diseases like Parkinson's, Alzheimer's, cystic fibrosis and cancer. Current trends include improving viral vectors and combining gene and cell therapies.
Gene therapy
Gene therapy is an approach to treating diseases by modifying or correcting abnormal genes. It can involve replacing a mutated gene, inactivating an abnormal gene, or introducing a new gene. While the concept was introduced in the 1960s, the first approved human gene therapy trial took place in 1990. Since then, gene therapy has successfully treated various diseases like blindness, immune deficiencies, and Parkinson's disease symptoms. Viral and non-viral vectors are used to deliver therapeutic genes, with both methods having advantages and disadvantages. Ongoing research continues to expand the diseases that can be treated with this promising approach.
1. gene therapy
Gene therapy involves inserting normal genes into a person's cells to treat a disease. There are several strategies for gene therapy, including ex vivo and in vivo methods. Viral vectors are commonly used to deliver therapeutic genes to target cells. However, gene therapy has faced challenges such as short-lived effects, immune responses, and safety issues with viral vectors. Continued research is working to overcome these issues and further develop promising applications of gene therapy.
Gene therapy
BASICS OF GENE THERAPY
INTRODUCTION,HISTORY,TYPES, USES, ADVANTAGES, DISADVANTAGES, DRAWBACKS, GENETIC ENGINEERING,REGULATION
Gene theary seminar
Gene therapy involves introducing genetic material into cells to treat disease. It is used for inherited disorders, cancers, and infectious diseases. Viruses are commonly used as vectors to deliver therapeutic genes, though safety issues exist. Some early successes included treating severe combined immunodeficiency using retroviruses to deliver the ADA gene ex vivo. However, the first death in gene therapy occurred treating ornithine transcarbamylase deficiency using an adenovirus vector, highlighting the risks. Improved delivery methods like liposomes may help overcome current limitations and advance this promising approach.
Gene therapy
Gene therapy , Nucleic acids , GENES , ADA-SCID(Severe combined immunodeficiency) , APPROACHES IN GENE THERAPY : Types of gene therapy , somatic gene therapy , germ line gene therapy , Gene modification , gene replacement , gene correction , gene augmentation , Gene transfer methods , viral gene transfer (biological) , non viral gene transfer : physical method ,chemical method , retrovirus vector system , adenovirus vector system , Adeno associated virus vector , Herpex simplex virus vector , Electroporation , Microinjection , Gene Gun , Calcium phosphate mediated DNA transfer , Liposome mediated gene transfer , Potential target diseases for Gene Therapy , GENE THERAPY USED TO TREAT TYPE I DIABETES , GENE THERAPY FOR CANCER TREATMENT , PARKINSON’S DISEASE , GENE THERAPY TREATMENT FOR ADA-SCID , GENE THERAPY FOR CYSTIC FIBROSI S, HEMOPHILIA , BLINDNESS
Gene therapy , Nucleic acids , GENES , ADA-SCID(Severe combined immunodeficiency) , APPROACHES IN GENE THERAPY : Types of gene therapy , somatic gene therapy , germ line gene therapy , Gene modification , gene replacement , gene correction , gene augmentation , Gene transfer methods , viral gene transfer (biological) , non viral gene transfer : physical method ,chemical method , retrovirus vector system , adenovirus vector system , Adeno associated virus vector , Herpex simplex virus vector , Electroporation , Microinjection , Gene Gun , Calcium phosphate mediated DNA transfer , Liposome mediated gene transfer , Potential target diseases for Gene Therapy , GENE THERAPY USED TO TREAT TYPE I DIABETES , GENE THERAPY FOR CANCER TREATMENT , PARKINSON’S DISEASE , GENE THERAPY TREATMENT FOR ADA-SCID , GENE THERAPY FOR CYSTIC FIBROSI S, HEMOPHILIA , BLINDNESS
Gene therapy
This document provides information about gene therapy. It discusses that gene therapy involves genetically modifying patient cells to treat or alleviate disease. There are two main types - ex vivo therapy where cells are modified outside the body and transplanted back in, and in vivo therapy where genetic material is directly transferred into patient cells. Viruses like retroviruses, adenoviruses, and lentiviruses are often used as vectors to deliver genetic material due to their ability to efficiently transfer genes. The document outlines different applications of gene therapy and discusses strategies used depending on disease characteristics.
Gene therapy- The hope beyond Myth
Gene therapy is an experimental technique that uses genes to treat or prevent disease. It works by inserting a normal gene to replace a defective gene that is causing disease. Researchers are studying gene therapy for diseases like cancer, HIV, hemophilia, blindness, and Parkinson's disease. There are two main types - germline gene therapy, which results in permanent changes that can be inherited, and somatic gene therapy, which only affects the patient. Gene delivery methods include viral vectors like retroviruses and adenoviruses, as well as non-viral methods using physical approaches or chemical carriers like liposomes and polymers. Some successful applications of gene therapy include treating blindness and reducing Parkinson's disease symptoms.
Human gene therapy
Gene Therapy, Somatic cell gene therapy, germ line gene therapy, classical gene therapy, non-classical gene therapy, targets of gene therapy, barriers of gene therapy, ex vivo gene therapy, in vivo gene therapy, vectors for gene delivery, antisense therapy
Gene therapy
These slide include gene therapy defines with their types like Germ line gene therapy,Somatic gene therapy.
with Need of Gene therapy
strategies of gene therapy
Methods of Gene transfer & with
GENE THERAPY FOR INHERITED DISORDERS
Gene therapy
This document discusses gene therapy, including:
- Gene therapy involves inserting a normal gene to replace an abnormal gene responsible for disease.
- There are two main types: germ line therapy affects future generations, while somatic therapy only affects the individual.
- The basic process involves researching the defective gene, copying the normal gene, and inserting it into cells.
- Gene therapy could potentially replace defective genes, deliver genes to treat cancer or provide immunity, and stimulate tissue growth or healing. However, it also faces challenges like high costs and ensuring genes only target intended cells. Examples where it has been used include hemophilia, blindness, cancer, and Parkinson's disease.
Gene therapy
It is a form of therapy that involves inserting one or more corrective genes that have been designed in the laboratory, into the genetic material of a patient's cells to cure a genetic disease.
Types: somatic and germ cell gene therapy.
Submitted to: Dr. Ankit Sharma
Strategies of gene therapy
Gene therapy involves introducing DNA into a patient's cells to treat a disease. There are four main strategies of gene therapy: gene augmentation therapy which adds a functional gene; targeted killing of specific cells like cancer cells; targeted mutation correction; and targeted inhibition of gene expression. Gene therapy shows promise for diseases like cystic fibrosis, hemophilia, cancer and more. Challenges remain around safely delivering genes to the right cells and avoiding immune responses.
GENE THERAPHY
This document provides an overview of gene therapy. It defines key terms like genetics, genes, chromosomes, and therapy. It explains that gene therapy involves inserting a normal gene to replace an abnormal gene causing disease. Viruses and non-viral methods can be used as vectors to deliver therapeutic genes. While some gene therapies have shown promise for diseases like Parkinson's and immune deficiencies, the field has also faced challenges. Safety issues in early trials halted some research, but recent studies demonstrate progress in refining methods and potentially treating diseases like sickle cell anemia.
Gene Therapy
In this slide, You will get to learn abut Gene Therapy and different types of gene therapy. Various method of Gene Therapy and Advantage & Disadvantage and Recent advances in Gene Therapy.
Gene therapy
Basic principles of genetics and the basic understanding of gene therapy and its applications in therapeutics.
Gene therapy for Biotechnologist
This document discusses gene therapy, including its history, mechanisms, applications, challenges, and recent developments. It provides an overview of the first human gene therapy trials in 1990 for severe combined immunodeficiency, as well as both successful and unsuccessful early gene therapy cases. Recent progress includes using gene therapy to potentially treat Parkinson's disease, cancer, blood disorders, and inherited blindness. Overall, the document outlines the key concepts and timeline of gene therapy from its beginnings to current research.
What's hot (20)
Similar to Gene therapy
Gene therapy
This document discusses gene therapy, including its strategies, methods of delivery, history, and applications. It provides an overview of key concepts such as:
1. Gene therapy aims to treat genetic diseases by inserting normal genes into cells to compensate for abnormal genes. Strategies include gene replacement, gene augmentation, and gene inhibition.
2. Viruses are commonly used as vectors to deliver therapeutic genes. Retroviruses and adenoviruses integrate into the genome but can cause mutations, while adenoviruses are safer but less efficient.
3. The basic process involves isolating the normal gene, inserting it into a viral vector, infecting target cells, and having the cells produce functional proteins to return to
Gene therapy
Gene therapy involves inserting normal genes into cells to treat genetic diseases. There are two main methods - using viruses as vectors to deliver genes (viral vectors) or delivering naked DNA. Researchers are studying gene therapy for diseases like cancer, HIV, hemophilia and more. Some successes include treating blindness caused by a genetic defect using a virus to deliver a healthy gene to the eyes. Gene therapy has also reduced Parkinson's disease symptoms by delivering a gene to the brain to increase inhibitory neurotransmitters. While offering hope, gene therapy also faces challenges in terms of safety, cost and ethical issues.
Gene therapy
Gene therapy involves introducing genes into cells to treat or cure diseases. It works by correcting defective genes that cause illnesses. The first approved human gene therapy trial took place in 1990 in the US and treated a patient with ADA-SCID. There are two main types of gene therapy - somatic cell gene therapy, which treats genes in body cells but is not inherited, and germline gene therapy, which treats genes in reproductive cells and can be passed to offspring. Gene therapy approaches include in vivo delivery of genes directly into tissues and ex vivo therapy involving culturing and modifying cells outside the body before reinsertion. Viral and non-viral vectors are used to transport therapeutic genes into target cells.
Gene therapy.pptxjjjjnnnsnskskslsllssnnznzj
Gene therapy involves inserting genes into an individual's cells and tissues to treat disease. It can replace mutated genes, inactivate genes, introduce new genes, or cause cancer cells to kill themselves. Viral and non-viral vectors are used to deliver genes. Gene therapy has been applied to treat genetic disorders, cancer, heart disease, and more. Recent advances include using gene therapy to regenerate heart muscle cells, treat Sanfilippo syndrome and brain cancers, and combining cellular and gene therapies for breast cancer. RNA and DNA can be estimated using reactions that form colored complexes measured spectrophotometrically.
NUCLEIC ACID BASED THERAPEUTIC DELIVERY SYSTEM by pramesh..pptx
Name of the title: Nucleic Acid-Based Therapeutic Delivery System.
It includes information about nucleic acid, gene therapy, and its type, a method to deliver the desired DNA, i.e., vectors and their types, with proper examples and diagrams, and how these things help in delivering a nucleic acid-based therapeutic drug delivery system.
Gene therapy
This will provide you information about gene therapy, its types, methods of gene delivery and some potential target diseases for gene therapy.
GENE THERAPY.1.pptx
Above slides consist of detailed information of gene therapy,including types, methods, future needs along with advantages and disadvantages
Gene therapy
Gene therapy is the process of inserting genes into cells to prevent, treat or cure wide range of diseases. Gene therapy primarily involves genetic manipulations in animals or humans to correct a disease. Gene augmentation therapy: a DNA is inserted into the Genome to replace the missing gene product.Gene inhibition therapy: the antisense gene inhibits the expression of the dominant gene.
Gene therapy
This presentation focuses on the science of Gene Therapy, the techniques of germ-line and somatic gene therapy and the mechanism of curing diseases and disorders using gene therapy. The presentation starts by discussing some common basic terms from genetics and moves on to the historical development of gene therapy techniques in chronological order. The different types of gene therapy techniques and their mechanisms have been discussed in detail subsequently. In concluding slides, some commercially available gene therapy products are mentioned and challenges of gene-therapy techniques have been highlighted.
Gene therapy ppt
Gene therapy involves inserting normal genes into patients to replace abnormal genes that cause disease. It is being studied for many diseases like immunodeficiencies, hemophilia, Parkinson's, and cancer. The first gene therapy occurred in 1990 and involved treating a genetic immune deficiency. While it offers potential cures, there are also risks and ethical concerns around its use.
Gene expression
Introduction
Approaches to Gene Therapy
Vectors in Gene Therapy
Non-viral Methods
Physical Methods for Improving DNA Transfer
Chemical Methods for Improving DNA Transfer
Advantages and Disadvantages of Gene Therapy
Applications of Gene Therapy
Challenges
Gene therapy types advantags disadvantages
Gene therapy involves inserting normal genes into patients to replace abnormal genes responsible for disease. There are two main types of gene therapy: ex vivo involves removing cells, modifying them, and reinserting them; in vivo delivers genes directly into target tissues. Viral and non-viral vectors are used to deliver genes. While gene therapy has potential to treat many diseases, it also has disadvantages like short-term effects and safety risks that must still be addressed.
Genetherapy : An Overview
Gene therapy involves the insertion of a functioning gene into cells to correct a cellular dysfunction
KEY WORDS : GENETICS, MUTATION , GENETIC ENGINEERING.
Gene therapy
Gene therapy involves introducing normal genes into cells to replace missing or defective genes and correct genetic disorders. The first gene therapy treatment occurred in 1990 for SCID. There are two main types - germline therapy would alter the germ cells and be heritable, while somatic therapy only affects the individual. Delivery of genes requires vectors like viruses that can transport the new gene into target cells. Challenges include developing vectors that don't cause immune responses, achieving long-term expression of the gene, and addressing disorders influenced by multiple genes. Risks include insertional mutagenesis and the development of tumors.
Gene therapy
Gene therapy involves introducing genes into cells to treat or prevent disease. It works by delivering a therapeutic gene into a patient's target cells using a vector. This can replace an abnormal gene with a healthy one, inactivate a mutated gene, or introduce a new gene to fight disease. There are two main types - somatic gene therapy only affects treated cells while germline gene therapy results in permanent changes that can be inherited. Approaches include ex vivo gene therapy, which modifies cells outside the body before transplant, and in vivo gene therapy through direct delivery. While gene therapy holds promise to cure genetic diseases, it faces challenges like short-lived effects and safety risks.
Gene therapy
Gene therapy involves inserting normal genes into patients' cells to treat genetic diseases. There are two main types - germline therapy, which affects future generations, and somatic therapy, which only affects the patient. Gene therapy works by using modified viruses or non-viral methods to deliver normal genes to replace mutated ones. Some successful cases include treating blindness caused by a genetic eye disease and reducing Parkinson's disease symptoms. While offering hope for currently untreatable diseases, gene therapy faces challenges in delivery methods, costs, and ethical issues.
Gene therapy
This document discusses gene therapy, which involves introducing a normal functional gene into a patient's cells to correct a genetic disorder. It provides examples of genetic disorders that may be candidates for gene therapy, such as Down syndrome, cystic fibrosis, and sickle cell anemia. The document outlines the mechanisms of gene therapy, including using viral vectors to deliver therapeutic genes to targeted cells. Requirements for effective gene therapy and different methods like ex vivo and in vivo approaches are also summarized. Potential advantages include providing treatment for previously untreatable genetic diseases, while disadvantages include high costs and safety concerns.
Gene therapy
Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin
Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990. Between 1989 and February
2016, over 2,300 clinical trials had been conducted, more than half of them in phase I. Not all medical procedures that introduce alterations to a patient's genetic makeup can be
considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients. Gene therapy is defined by the
precision of the procedure and the intention of direct therapeutic effects.
Gene therapy
Gene therapy aims to treat diseases by introducing normal genes into cells containing defective genes. The first approved gene therapy occurred in 1990 and treated ADA-SCID. There are two main types of gene therapy - germline modifies heritable genes while somatic only affects treated cells. Viral and non-viral vectors are used to deliver genes, with retroviruses and adenoviruses commonly used viral vectors. Recent advances include gene therapies reducing symptoms for blindness and Parkinson's disease.
Gene Therapy
Gene therapy involves inserting functional genes into patients' cells to treat genetic diseases. It was first proposed in the 1960s and attempted in the 1970s. The first approved human gene therapy trial took place in 1990, treating a girl with severe combined immunodeficiency. Since then, gene therapy has been used experimentally to treat various diseases including cancer, cystic fibrosis, and HIV. There are two main approaches - ex vivo, where cells are removed and modified before being returned to the body, and in vivo, where genes are directly inserted into target tissues. Viruses are often used as vectors to deliver therapeutic genes, with retroviruses commonly used for ex vivo therapy and adenoviruses for in vivo.
Similar to Gene therapy (20)
NUCLEIC ACID BASED THERAPEUTIC DELIVERY SYSTEM by pramesh..pptx
NUCLEIC ACID BASED THERAPEUTIC DELIVERY SYSTEM by pramesh..pptx
Recently uploaded
BREEDING METHODS FOR DISEASE RESISTANCE.pptx
Plant breeding for disease resistance is a strategy to reduce crop losses caused by disease. Plants have an innate immune system that allows them to recognize pathogens and provide resistance. However, breeding for long-lasting resistance often involves combining multiple resistance genes
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
Although Artemia has been known to man for centuries, its use as a food for the culture of larval organisms apparently began only in the 1930s, when several investigators found that it made an excellent food for newly hatched fish larvae (Litvinenko et al., 2023). As aquaculture developed in the 1960s and ‘70s, the use of Artemia also became more widespread, due both to its convenience and to its nutritional value for larval organisms (Arenas-Pardo et al., 2024). The fact that Artemia dormant cysts can be stored for long periods in cans, and then used as an off-the-shelf food requiring only 24 h of incubation makes them the most convenient, least labor-intensive, live food available for aquaculture (Sorgeloos & Roubach, 2021). The nutritional value of Artemia, especially for marine organisms, is not constant, but varies both geographically and temporally. During the last decade, however, both the causes of Artemia nutritional variability and methods to improve poorquality Artemia have been identified (Loufi et al., 2024).
Brine shrimp (Artemia spp.) are used in marine aquaculture worldwide. Annually, more than 2,000 metric tons of dry cysts are used for cultivation of fish, crustacean, and shellfish larva. Brine shrimp are important to aquaculture because newly hatched brine shrimp nauplii (larvae) provide a food source for many fish fry (Mozanzadeh et al., 2021). Culture and harvesting of brine shrimp eggs represents another aspect of the aquaculture industry. Nauplii and metanauplii of Artemia, commonly known as brine shrimp, play a crucial role in aquaculture due to their nutritional value and suitability as live feed for many aquatic species, particularly in larval stages (Sorgeloos & Roubach, 2021).
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless ReproducibilityUniversity of Rennes, INSA Rennes, Inria/IRISA, CNRS
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...Abdul Wali Khan University Mardan,kP,Pakistan
hematic appreciation test is a psychological assessment tool used to measure an individual's appreciation and understanding of specific themes or topics. This test helps to evaluate an individual's ability to connect different ideas and concepts within a given theme, as well as their overall comprehension and interpretation skills. The results of the test can provide valuable insights into an individual's cognitive abilities, creativity, and critical thinking skillsbordetella pertussis.................................ppt
Bordettela is a gram negative cocobacilli spread by air born drop let
20240520 Planning a Circuit Simulator in JavaScript.pptx
Evaporation step counter work. I have done a physical experiment.
(Work in progress.)
Nucleophilic Addition of carbonyl compounds.pptx
Nucleophilic addition is the most important reaction of carbonyls. Not just aldehydes and ketones, but also carboxylic acid derivatives in general.
Carbonyls undergo addition reactions with a large range of nucleophiles.
Comparing the relative basicity of the nucleophile and the product is extremely helpful in determining how reversible the addition reaction is. Reactions with Grignards and hydrides are irreversible. Reactions with weak bases like halides and carboxylates generally don’t happen.
Electronic effects (inductive effects, electron donation) have a large impact on reactivity.
Large groups adjacent to the carbonyl will slow the rate of reaction.
Neutral nucleophiles can also add to carbonyls, although their additions are generally slower and more reversible. Acid catalysis is sometimes employed to increase the rate of addition.
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
The pygmy halfbeak Dermogenys colletei, is known for its viviparous nature, this presents an intriguing case of relatively low fecundity, raising questions about potential compensatory reproductive strategies employed by this species. Our study delves into the examination of fecundity and the Gonadosomatic Index (GSI) in the Pygmy Halfbeak, D. colletei (Meisner, 2001), an intriguing viviparous fish indigenous to Sarawak, Borneo. We hypothesize that the Pygmy halfbeak, D. colletei, may exhibit unique reproductive adaptations to offset its low fecundity, thus enhancing its survival and fitness. To address this, we conducted a comprehensive study utilizing 28 mature female specimens of D. colletei, carefully measuring fecundity and GSI to shed light on the reproductive adaptations of this species. Our findings reveal that D. colletei indeed exhibits low fecundity, with a mean of 16.76 ± 2.01, and a mean GSI of 12.83 ± 1.27, providing crucial insights into the reproductive mechanisms at play in this species. These results underscore the existence of unique reproductive strategies in D. colletei, enabling its adaptation and persistence in Borneo's diverse aquatic ecosystems, and call for further ecological research to elucidate these mechanisms. This study lends to a better understanding of viviparous fish in Borneo and contributes to the broader field of aquatic ecology, enhancing our knowledge of species adaptations to unique ecological challenges.
Applied Science: Thermodynamics, Laws & Methodology.pdf
When I was asked to give a companion lecture in support of ‘The Philosophy of Science’ (https://shorturl.at/4pUXz) I decided not to walk through the detail of the many methodologies in order of use. Instead, I chose to employ a long standing, and ongoing, scientific development as an exemplar. And so, I chose the ever evolving story of Thermodynamics as a scientific investigation at its best.
Conducted over a period of >200 years, Thermodynamics R&D, and application, benefitted from the highest levels of professionalism, collaboration, and technical thoroughness. New layers of application, methodology, and practice were made possible by the progressive advance of technology. In turn, this has seen measurement and modelling accuracy continually improved at a micro and macro level.
Perhaps most importantly, Thermodynamics rapidly became a primary tool in the advance of applied science/engineering/technology, spanning micro-tech, to aerospace and cosmology. I can think of no better a story to illustrate the breadth of scientific methodologies and applications at their best.
Equivariant neural networks and representation theory
Or: Beyond linear.
Abstract: Equivariant neural networks are neural networks that incorporate symmetries. The nonlinear activation functions in these networks result in interesting nonlinear equivariant maps between simple representations, and motivate the key player of this talk: piecewise linear representation theory.
Disclaimer: No one is perfect, so please mind that there might be mistakes and typos.
dtubbenhauer@gmail.com
Corrected slides: dtubbenhauer.com/talks.html
如何办理(uvic毕业证书)维多利亚大学毕业证本科学位证书原版一模一样
原版纸张【微信：741003700 】【(uvic毕业证书)维多利亚大学毕业证】【微信：741003700 】学位证，留信认证（真实可查，永久存档）offer、雅思、外壳等材料/诚信可靠,可直接看成品样本，帮您解决无法毕业带来的各种难题！外壳，原版制作，诚信可靠，可直接看成品样本。行业标杆！精益求精，诚心合作，真诚制作！多年品质 ,按需精细制作，24小时接单,全套进口原装设备。十五年致力于帮助留学生解决难题，包您满意。
本公司拥有海外各大学样板无数，能完美还原海外各大学 Bachelor Diploma degree, Master Degree Diploma
1:1完美还原海外各大学毕业材料上的工艺：水印，阴影底纹，钢印LOGO烫金烫银，LOGO烫金烫银复合重叠。文字图案浮雕、激光镭射、紫外荧光、温感、复印防伪等防伪工艺。材料咨询办理、认证咨询办理请加学历顾问Q/微741003700
留信网认证的作用:
1:该专业认证可证明留学生真实身份
2:同时对留学生所学专业登记给予评定
3:国家专业人才认证中心颁发入库证书
4:这个认证书并且可以归档倒地方
5:凡事获得留信网入网的信息将会逐步更新到个人身份内，将在公安局网内查询个人身份证信息后，同步读取人才网入库信息
6:个人职称评审加20分
7:个人信誉贷款加10分
8:在国家人才网主办的国家网络招聘大会中纳入资料，供国家高端企业选择人才
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...University of Maribor
Slides from talk:
Aleš Zamuda: Remote Sensing and Computational, Evolutionary, Supercomputing, and Intelligent Systems.
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Inter-Society Networking Panel GRSS/MTT-S/CIS Panel Session: Promoting Connection and Cooperation
https://www.etran.rs/2024/en/home-english/Cytokines and their role in immune regulation.pptx
This presentation covers the content and information on "Cytokines " and their role in immune regulation .
Micronuclei test.M.sc.zoology.fisheries.
Current Ms word generated power point presentation covers major details about the micronuclei test. It's significance and assays to conduct it. It is used to detect the micronuclei formation inside the cells of nearly every multicellular organism. It's formation takes place during chromosomal sepration at metaphase.
ESR spectroscopy in liquid food and beverages.pptx
With increasing population, people need to rely on packaged food stuffs. Packaging of food materials requires the preservation of food. There are various methods for the treatment of food to preserve them and irradiation treatment of food is one of them. It is the most common and the most harmless method for the food preservation as it does not alter the necessary micronutrients of food materials. Although irradiated food doesn’t cause any harm to the human health but still the quality assessment of food is required to provide consumers with necessary information about the food. ESR spectroscopy is the most sophisticated way to investigate the quality of the food and the free radicals induced during the processing of the food. ESR spin trapping technique is useful for the detection of highly unstable radicals in the food. The antioxidant capability of liquid food and beverages in mainly performed by spin trapping technique.
Nucleic Acid-its structural and functional complexity.
This presentation explores a brief idea about the structural and functional attributes of nucleotides, the structure and function of genetic materials along with the impact of UV rays and pH upon them.
Bob Reedy - Nitrate in Texas Groundwater.pdf
Presented at June 6-7 Texas Alliance of Groundwater Districts Business Meeting
Recently uploaded (20)
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Deep Software Variability and Frictionless Reproducibility
Deep Software Variability and Frictionless Reproducibility
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
THEMATIC APPERCEPTION TEST(TAT) cognitive abilities, creativity, and critic...
bordetella pertussis.................................ppt
bordetella pertussis.................................ppt
20240520 Planning a Circuit Simulator in JavaScript.pptx
20240520 Planning a Circuit Simulator in JavaScript.pptx
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
Applied Science: Thermodynamics, Laws & Methodology.pdf
Applied Science: Thermodynamics, Laws & Methodology.pdf
Equivariant neural networks and representation theory
Equivariant neural networks and representation theory
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Cytokines and their role in immune regulation.pptx
Cytokines and their role in immune regulation.pptx
ESR spectroscopy in liquid food and beverages.pptx
ESR spectroscopy in liquid food and beverages.pptx
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Gene therapy
- 1. Gene Therapy Presented by- Yamini Meshram M.Sc Sem-3 (Biotechnology) Dr. Ambedkar College, Deekshabhoomi, Nagpur Department of Biochemistry and Biotechnology
- 2. Content • Introduction • History • Types • Gene Delivery • Vectors • Advantages and Disadvantages • Reference
- 3. Introduction • Gene therapy:- Gene therapy is the insertion of genes into an individual's cells and tissues to treat a disease, and hereditary diseases in which a defective mutant gene is replaced with a functional one. • In most gene therapy studies, a "normal" gene is inserted into the genome to replace an "abnormal," disease-causing gene. • A carrier called a vector must be used to deliver the therapeutic gene to the patient's target cells.
- 4. History • In 1972, Theodore Friedmann and Richard Roblin published a paper in Science called "Gene therapy for human genetic disease?" which cited Stanfield Roger's proposal in 1970 that "good DNA" could be used to replace defective DNA in people with genetic disorders. • The first patient to be treated with gene therapy was a four year old girl treated at the NIH Clinical Center in 1990. She had a congenital disease called adenosine deaminase (ADA) deficiency which severely affects immunity and the ability to fight infections. • In 1985, Anderson and colleague Michael Blease started working together to demonstrate how cells from people with ADA deficiency could be modified in tissue culture. They used a retrovirus as a vector to carry the correct ADA gene into the cells.
- 5. • In 1986, they tried transferring the correct genes into the bone marrow of animals, but in 1988, found that transferring them to white blood cells was much more successful, with a dramatic increase in the amount of the correct genes being taken up by cells. • In 1989, the researchers teamed up with Dr. Steven Rosenberg to test how safe and effective the gene therapy would be in cancer patients. The team cultured tumor infiltration lymphocytes cells (TIL cells) from people with malignant melanoma. • In 1990, the four-year old girl and another nine-year old girl with ADA deficiency were infused with their own corrected cells over two years and in 1993, the team used the gene therapy to treat newborn infants with ADA deficiency. The corrected ADA genes were transferred to immature blood cells obtained from the babies' umbilical cords.
- 6. Types • Somatic Gene Therapy:- In somatic gene therapy, the therapeutic genes are transferred into the somatic cells, or body, of a patient • Germ Line Gene Therapy:- In germ line gene therapy, Germ cells, i.e., sperm or ovum, are modified by the introduction of functional genes, which are integrated into their genomes. This would allow the therapy to be heritable and passed on to later generations. • Preventive Gene Therapy:- Preventive gene therapy is the repair of a gene with a mutation associated with a progressive disease, prior to the expression of a medical condition, in order to prevent that expression.
- 7. • Gene delivery is the process of introducing foreign DNA into host cells. • By two methods genes can be delivered. They are as follows:- Viral Vectors. Non Viral Vectors. Gene Delivery
- 8. Vectors Viral Vectors • All viruses bind to their hosts and introduce their genetic material into the host cell as part of their replication cycle. • A number of viruses have been used for human gene therapy. • Example:- retrovirus, adenovirus, lent virus, herpes simplex virus, vaccinia, pox virus, and adenoassociated virus.
- 9. Non-Viral Vectors: • Non-viral methods can present certain advantages over viral methods, such as large scale production and low host immunogenicity. • There are several methods for non-viral gene therapy, for example the injection of naked DNA, electroporation, the gene gun, magnetofection, and the use of oligonucleotides, lipoplexes, dendrimers, and inorganic nanoparticles.
- 10. Advantages • Gene silencing is a concept that in itself is self-efficient for management of many diseases. • Gene therapy has the potential to eliminate and prevent hereditary diseases, such as cystic fibrosis, and is a possible cure for heart disease, AIDS and cancer. • Gives an advantage to a person born with genetic disorder to live life in a normal way by replacing non-functional gene with a functional one.
- 11. Disadvantages • Irregular immune responses. • Viral vectors may introduce toxicity, as well as immune and inflammatory responses. • Multi-gene disorders such as heart disease, high blood pressure, Alzheimer’s disease, arthritis, and diabetes cannot be treated through this therapy as conditions or disorders that arise only from mutations in a single gene are the best candidates for gene therapy. • Chances of inducing iatrogenic (physician induced) tumours in human beings. • Short-lived nature of gene therapy.
- 12. Reference • https://www.sciencedaily.com/terms/gene_therapy.htm • https://www.news-medical.net/health/Gene-Therapy-History.aspx • http://www.biotechnologynotes.com/gene-therapy/gene-therapy- meaning-types-advantages-and-disadvantages/823